Medigen Vaccine Biologics
TWD47.60
0
-TWD1.60-3.25% 05:30 Today
Statistics
Day High
48.85
Day Low
47.5
52W High
72.2
52W Low
33.5
Volume
1,694,704
Avg. Volume
4,271,061
Mkt Cap
15.65B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 18Expected
Q1 2026
Q2 2026
Next
0.03
0.06
0.09
0.12
Expected EPS
0.12246708815999999
Actual EPS
N/A
Financials
-45.94%Profit Margin
Unprofitable613.17MRevenue
-281.71MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Medigen Vaccine Biologics Corporation, a biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan. It develops enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection with severe complications; and Quadrivalent influenza vaccine, which is in Phase III clinical trial for the treatment of influenza viruses. The company also develops dengue vaccines, which has completed Phase II clinical trial to treat dengue; anti respiratory syncytial virus (RSV), which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19. The company was incorporated in 2012 and is headquartered in Zhubei, Taiwan. Medigen Vaccine Biologics Corporation operates as a subsidiary of Medigen Biotechnology Corp.
Show More
CEO
Leo Lee
Employees
1226
Country
Taiwan
ISIN
TW0006547003
Listings
0 Comments
Share your thoughts
FAQs
What is Medigen Vaccine Biologics stock price today?▼
The current price of 6547.TWO is TWD47.60 TWD — it has decreased by -3.25% in the past 24 hours. Watch Medigen Vaccine Biologics stock price performance more closely on the chart.
What is Medigen Vaccine Biologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Medigen Vaccine Biologics stocks are traded under the ticker 6547.TWO.
Is Medigen Vaccine Biologics stock price growing?▼
6547.TWO stock has fallen by -3.64% compared to the previous week, the month change is a -21.71% fall, over the last year Medigen Vaccine Biologics has showed a +36.59% increase.
What is Medigen Vaccine Biologics market cap?▼
Today Medigen Vaccine Biologics has the market capitalization of 15.65B
When is the next Medigen Vaccine Biologics earnings date?▼
Medigen Vaccine Biologics is going to release the next earnings report on November 18, 2026.
What were Medigen Vaccine Biologics earnings last quarter?▼
6547.TWO earnings for the last quarter are 0.07 TWD per share, whereas the estimation was 0.06 TWD resulting in a +16.67% surprise. The estimated earnings for the next quarter are N/A TWD per share.
What is Medigen Vaccine Biologics revenue for the last year?▼
Medigen Vaccine Biologics revenue for the last year amounts to 613.17M TWD.
What is Medigen Vaccine Biologics net income for the last year?▼
6547.TWO net income for the last year is -281.71M TWD.
How many employees does Medigen Vaccine Biologics have?▼
As of November 3, 2026, the company has 1,226 employees.
In which sector is Medigen Vaccine Biologics located?▼
Medigen Vaccine Biologics operates in the Health & Wellness sector.
When did Medigen Vaccine Biologics complete a stock split?▼
The last stock split for Medigen Vaccine Biologics was on August 3, 2022 with a ratio of 1482.8057411:1000.
Where is Medigen Vaccine Biologics headquartered?▼
Medigen Vaccine Biologics is headquartered in Zhubei, Taiwan.